Caption Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Hold |
0
| – | – | – | 893 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 849 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 935 |
|
|
2022
Q4 | – | Sell |
-56,010
| Closed | -$1.41M | – | 965 |
|
|
2022
Q3 | $1.41M | Buy |
+56,010
| New | +$1.41M | 0.02% | 92 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 1008 |
|
|
2022
Q1 | – | Sell |
-99,900
| Closed | -$2.63M | – | 1101 |
|
|
2021
Q4 | $2.63M | Buy |
+99,900
| New | +$2.63M | 0.03% | 143 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 1020 |
|
|
2021
Q2 | – | Sell |
-4,500
| Closed | -$450K | – | 905 |
|
|
2021
Q1 | $450K | Buy |
+4,500
| New | +$450K | 0.01% | 234 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 716 |
|
|
2020
Q3 | – | Sell |
-39,100
| Closed | -$6.1M | – | 721 |
|
|
2020
Q2 | $6.1M | Buy |
39,100
+26,200
| +203% | +$4.09M | 0.2% | 15 |
|
|
2020
Q1 | $1.86M | Sell |
12,900
-22,516
| -64% | -$3.25M | 0.11% | 52 |
|
|
2019
Q4 | $7.24M | Buy |
+35,416
| New | +$7.24M | 0.24% | 9 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 534 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 488 |
|